Jericho Capital Asset Management L.P. Legend Biotech Corp Transaction History

Jericho Capital Asset Management L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$23.55 - $32.4 $4.78 Million - $6.58 Million	-203,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$27.5 - $39.61 $2.94 Million - $4.24 Million	107,000 Added 111.46%	203,000 $6.27 Million
Q2 2020 Aug 14, 2020	BUY	$36.1 - $42.56 $3.47 Million - $4.09 Million	96,000 New	96,000 $4.09 Million

225

74.3M

279K

350K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $5.71B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Jericho Capital Asset Management L.P., based on Form 13F filings with the SEC.

Stay updated on Jericho Capital Asset Management L.P. with notifications on news.